Renata F. Alvim
Rio De Janeiro, RJ, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
A Thermostable nasal spray dried COVID vaccine candidate.
Journal: International journal of pharmaceutics
Published: June 20, 2025
Potent Monoclonal Antibodies Against Circulating Yellow Fever Virus Strains from Donors Immunized with the 17D Vaccine.
Journal: The American journal of tropical medicine and hygiene
Published: January 29, 2025
Conformational stability of SARS-CoV-2 glycoprotein spike variants.
Journal: iScience
Published: April 29, 2022
Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001): A One Year Period Follow Up Phase 4 Study.
Journal: Frontiers in immunology
Published: April 12, 2022
Immunogenicity of SARS-CoV-2 Trimeric Spike Protein Associated to Poly(I:C) Plus Alum.
Journal: Frontiers in immunology
Published: February 27, 2022
From a recombinant key antigen to an accurate, affordable serological test: Lessons learnt from COVID-19 for future pandemics.
Journal: Biochemical engineering journal
Published: February 24, 2022
Polyclonal F(ab')2 fragments of equine antibodies raised against the spike protein neutralize SARS-CoV-2 variants with high potency.
Journal: iScience
Published: May 12, 2021
The immunodominant antibody response to Zika virus NS1 protein is characterized by cross-reactivity to self.
Journal: The Journal of experimental medicine
Published: March 12, 2021
Process intensification for the production of yellow fever virus-like particles as potential recombinant vaccine antigen.
Journal: Biotechnology and bioengineering
Published: October 06, 2020
Zika virus-like particles (VLPs): Stable cell lines and continuous perfusion processes as a new potential vaccine manufacturing platform.
Journal: Vaccine
Published: December 11, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026